Pfizer reveals new details on vaccine access to children

The company said it plans to file safety and efficacy data in early October, with FDA emergency authorization expected to follow.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting